News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Confirmed: Reckitt Benckiser Plc (RB.L) To Spin Off Heroin Treatment Business



7/28/2014 8:43:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Reckitt Benckiser (RB.L) plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival copycat versions of the drug.

Sales of Suboxone have slumped and Reckitt has two new pharmaceutical projects that could diversify revenue and boost the unit's market valuation.

The British company put Suboxone under strategic review in October and in April said it was leaning towards spinning off the business rather than a private sale.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Telegraph
Read at Guardian


comments powered by Disqus
Reuters
Telegraph
Guardian
   
Addiction

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES